Bristol-Myers Squibb Company (NYSE:BMY) and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases...
Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/hhQglcrw2ZI/231598.php
sport sport medical sport news
No comments:
Post a Comment